CatalystWireBeta

UK small-cap RNS · 26 Jun 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies

15:09

Nostrum Oil & Gas NOG £1.4m
Consent Solicitation
The 30 March maturity extension to 2030 is replaced by a long-term standstill with lower interest, because Kazakh restrictions on secured assets block the original structure. Maturities are not extended outright, and the Senior Unsecured Notes tender offer is dropped.

Balance-sheet stress / refinancing +0.0% on the day

Moved: Delayed SSN and SUN coupon payment: Coupons unpaid; licences applied for → Consent solicitation launched; standstill replaces extension · Kazakhstan withholding tax disputes: First instance court rejected 2018-2019 challenge → Tax dispute now restricting secured assets
14:13

Scancell Holdings SCLP £124m
Response to Press Speculation
Scancell is the acquirer of Neuphoria in an all-share reverse merger, not the target of a bid, so there is no takeover approach for its shareholders.

Large acquisition / reverse takeover first since Oct 2023 −3.2% on the day

Moved: new: Neuphoria reverse merger – Advanced discussions; no firm agreement · iSCIB1+ melanoma registration path: IND cleared, Fast Track granted; financing unsecured → Financing talks ongoing; still unsecured
11:27

Union Jack Oil UJO £2.4m
Adjournment of Annual General Meeting
Union Jack Oil plc (AIM: UJO), a UK and USA focused onshore hydrocarbon production, development and exploration company, announces that the Annual General Meeting ("AGM") due to be held today has been adjourned until further notice.

Takeover target +0.0% on the day
07:06

Avon Technologies plc AVON £700m
NG IHPS Delivery Orders
Team Wendy wins the highest share of both DLA and ACC NG-IHPS delivery orders, adding to a Team Wendy book that had shrunk and giving DoW visibility.

Segment turn £30.3m · 4% of mcap +0.9% on the day

Moved: Team Wendy DoW helmet ramp-up: IHPS and ACH at contract rates; testing backlog → New NG-IHPS delivery orders received
07:00

Defence Holdings PLC ALRT £16m
Results of Fundraising Results
The placing completed at 1p, a 24.81% discount to the prior close, issuing 400m shares and lifting the share count to about 2.87bn. It funds a pre-revenue company but dilutes holders heavily.

Dilutive fundraise £4.0m · 25% of mcap −4.1% on the day

Moved: Discounted placing of up to £4m: Accelerated bookbuild launched; broker offer open → Placing completed, oversubscribed; admission pending
07:00

Blue Star Capital BLU £1.8m
Holding(s) in Company Holding
07:00

Cirata CRTA £8.8m
Result of Placing and Subscription Fundraise
Cirata plc (LSE: CRTA) is pleased to announce the successful completion of the oversubscribed bookbuild in respect of its conditional placing and subscription (together the "Fundraising") announced on 25 June 2026 (the "Launch Announcement"), raising, in …

Dilutive fundraise 12% of mcap −4.0% on the day
07:00

Zenith Energy LTD.Com Shs ZEN £29m
ICSID Arbitration against the Republic of Tunisia
("Zenith" or the "Company") (LSE: ZEN; OSE: ZENA; XSAT: ZENA SDR), the listed international energy production and development company, is pleased to confirm that the International Centre for Settlement of Investment Disputes ("ICSID") has now announced the …

Legal & regulatory outlook positive −5.3% on the day

Moved: Tunisian authorities dispute and oil confiscation: ICSID arbitration; Tunisia concedes ownership → Post-hearing briefs; award expected Q1 2027
07:00

Distribution Finance Capital Holdings DFCH £118m
Trading Statement Trading update
("DF Capital" or the "Company" together with its subsidiaries the "Group")

Upgrade / downgrade cycle ahead of expectations +10.1% on the day
07:00

Zephyr Energy ZPHR £65m
Acquisition of additional acreage & divestment
The two Powder River undeveloped acreage sales closed, bringing in about US$2.2m net cash and recouping more of the US$7.3m acquisition price while the Paradox project is being scaled up.

Sale process / strategic review +1.6% on the day

Moved: Paradox marketing / farm-in partner: Advanced significantly; offtake not yet finalised → Farm-out talks continue with enlarged acreage
07:00

Crism Therapeutics Corporation CRTX £7.0m
Final Results Results
Loss widened to £1.90m from £0.61m as R&D rose to £908k ahead of the Phase 2 trial; cash was £1.13m at year end, but regulatory milestones were met and funding has since been added.

Project milestones £2.7m · 39% of mcapoutlook mixed, loweredfirst in 9 months +0.0% on the day

Moved: Irinotecan-ChemoSeed glioblastoma Phase 2: First batch made; dosing guided to H1 2026 → Funded; manufacturing done, site activation advanced
07:00

Thruvision Group THRU £8.5m
Results for the year ended 31 March 2026 Results
FY26 results match the revenue given on 8 April and EBITDA in line with market expectations. The Board adds no numeric guidance, only confidence in FY27 growth, so this is not a raise.

Balance-sheet stress / refinancing £6.0m · 71% of mcapin lineoutlook positivefirst since Oct 2023 +0.0% on the day

Moved: Going concern and cash runway: FY26 revenue in range; cash £2.0m → FY26 results: cash £2.0m, no debt · Pricing and cost reset: Box Clever in progress; subscription launched → Initial savings achieved early FY27